Stock PSG PHARMASGP HOLDING SE
Add to a list
To use this feature you must be a member
Log inSign up

Highlights PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Market Closed - Xetra
Other stock markets
 16:36:21 09/05/2024 BST 		5-day change 1st Jan Change
23 EUR -0.86% Intraday chart for PharmaSGP Holding SE +2.68% +2.22%
04-29 PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023
CI
PharmaSGP Holding SE Announces Changes to Dividend Policy
CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.
CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023
CI
PharmaSGP Completes EUR2 Million Share Buyback Program
MT
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2022
CI
PharmaSGP Holding SE commences an Equity Buyback Plan, under the authorization approved on May 28, 2020.
CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2022
CI
PharmaSGP Holding SE Reaffirms Earnings Guidance for the Year 2022
CI
PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022
CI
PharmaSGP Holding SE Approves Dividend
CI
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2021
CI
PharmaSGP Holding SE Provides Revenues Guidance for the Financial Year 2022
CI
PharmaSGP Proposes Dividend for 2021
CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSG Stock
  4. News PharmaSGP Holding SE
  5. Highlights